Japan's Mebiopharm Disappoints In First Aim Market Listing
This article was originally published in PharmAsia News
Executive Summary
Mebiopharm of Japan, the first company to be listed on Japan's Aim stock market for professional investors, managed to attract a much lower price than expected during its first week